Surgical aortic valve replacement
An operation in which a surgeon replaces a diseased aortic valve with a mechanical valve or a biological (tissue) valve. It is the comparison for TAVR in the PARTNER 3 and Evolut Low Risk trials. NHLBI lists stroke and blood clots among the risks of valve replacement, together with injury to the kidneys or heart.
Also called SAVR · Open-heart aortic valve replacement
- Intervention
- In this atlas
Overview
Technical summary
Open-heart valve replacement, as the comparison for catheter replacement. NHLBI separates the surgical route from the catheter route and describes mechanical and biological (tissue) valves. In PARTNER 3 the registry describes the comparison as SAVR with a commercially available bioprosthetic valve; the Evolut Low Risk registry says commercial SAVR with a commercially approved surgical bioprosthesis. This record gives no outcome figures of its own: the trial claims are filed under TAVR and the CoreValve and Evolut record.
About this intervention
- Type
- Procedure
- Mechanism
- The diseased valve is removed during open-heart surgery and replaced with a mechanical or biological valve (NHLBI).
Claims and evidence
No claims are published for this intervention yet.
Record details
- Record id
cardio:surgical-aortic-valve-replacement- Content hash
6202ac53023605e372fe3a0ccdb5e28db97d5b356d0bfb45c9066da7f99d6f7b